MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
InfuSystem Holdings Retained Earnings 2011-2026 | INFU
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings InfuSystem Holdings
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -59.3 M | -53.9 M | - | -61.4 M | -62.7 M | -61.6 M | -41.1 M | -40 M | -43.7 M | -47.1 M | -48.7 M | -47.2 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -40 M | -62.7 M | -51.5 M |
Quarterly Retained Earnings InfuSystem Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -61.4 M | -61.5 M | -60.6 M | -57.5 M | -58.2 M | -59.3 M | -59.7 M | -58.6 M | -58.7 M | -59.4 M | -59.8 M | -59.3 M | -59.4 M | - | -58.3 M | -53.9 M | -43 M | -42.6 M | -43.4 M | -44 M | -44 M | -44 M | -44 M | -61.4 M | -61.4 M | -61.4 M | -61.4 M | -62.7 M | -62.7 M | -62.7 M | -62.7 M | -61.6 M | -61.6 M | -61.6 M | -61.6 M | -41.1 M | -41.1 M | -41.1 M | -41.1 M | -40.9 M | -40.9 M | -40.9 M | -40.9 M | -43.7 M | -43.7 M | -43.7 M | -43.7 M | -47.1 M | -47.1 M | -47.1 M | -47.1 M | -48.7 M | -48.7 M | -48.7 M | -48.7 M | -47.2 M | -47.2 M | -47.2 M | -47.2 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -40.9 M | -62.7 M | -51.9 M |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
13.7 B | $ 16.47 | -1.08 % | $ 8.45 B |  USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
19.4 B | $ 74.46 | -0.25 % | $ 40.4 B |  Schweiz |
 |
The Cooper Companies
COO
|
7.64 B | $ 69.5 | -1.13 % | $ 13.8 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
-191 M | $ 7.04 | - | $ 59.7 K | USA |
 |
Ekso Bionics Holdings
EKSO
|
-262 M | $ 9.6 | -1.54 % | $ 23.3 M | USA |
 |
BioLife Solutions
BLFS
|
-335 M | $ 19.0 | -1.4 % | $ 875 M | USA |
 |
AtriCure
ATRC
|
-413 M | $ 28.76 | -1.47 % | $ 1.37 B | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 115.08 | -1.41 % | $ 5.57 B | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 58.1 | -0.54 % | $ 2.92 B | USA |
 |
Harvard Bioscience
HBIO
|
-215 M | $ 5.53 | - | $ 245 M | USA |
 |
iRhythm Technologies
IRTC
|
-803 M | $ 115.36 | -1.59 % | $ 3.69 B | USA |
 |
Repro Med Systems
KRMD
|
-32 M | $ 4.25 | -0.23 % | $ 196 M | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 178.34 | -0.08 % | $ 9.51 B | USA |
 |
Microbot Medical
MBOT
|
-104 M | $ 2.32 | -1.91 % | $ 106 M |  Israel |
 |
Milestone Scientific
MLSS
|
-134 M | $ 0.29 | - | $ 23.8 M | USA |
 |
Envista Holdings Corporation
NVST
|
-440 M | $ 25.51 | -1.22 % | $ 4.29 B | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 48.53 | - | $ 160 M | USA |
 |
ICU Medical
ICUI
|
691 M | $ 121.67 | -1.08 % | $ 3 B | USA |
 |
ResMed
RMD
|
3.61 B | $ 224.04 | -0.34 % | $ 32.7 B | USA |
 |
Retractable Technologies
RVP
|
13.9 M | $ 0.71 | -0.07 % | $ 21.3 M | USA |
 |
Isoray
ISR
|
-335 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
7.01 B | $ 449.17 | -0.75 % | $ 160 B | USA |
 |
STAAR Surgical Company
STAA
|
-148 M | $ 21.44 | 2.29 % | $ 1.06 B | USA |
 |
Stereotaxis
STXS
|
-583 M | $ 1.85 | -1.86 % | $ 168 M | USA |
 |
LeMaitre Vascular
LMAT
|
185 M | $ 109.83 | 0.61 % | $ 2.49 B | USA |
 |
Teleflex Incorporated
TFX
|
3.15 B | $ 114.86 | -0.2 % | $ 5.13 B | USA |
 |
Merit Medical Systems
MMSI
|
824 M | $ 66.72 | -1.61 % | $ 3.95 B | USA |
 |
Utah Medical Products
UTMD
|
129 M | $ 63.75 | 1.3 % | $ 207 M | USA |
 |
Predictive Oncology
POAI
|
-414 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
-463 M | $ 21.68 | -5.49 % | $ 1.46 B | USA |
 |
West Pharmaceutical Services
WST
|
4.37 B | $ 258.0 | 0.4 % | $ 18.7 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-1.56 B | $ 11.45 | -1.63 % | $ 2.28 B | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
STERIS plc
STE
|
2.48 B | $ 219.18 | -0.37 % | $ 21.6 B | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 9.51 | -3.35 % | $ 389 M | USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 154.32 | -0.59 % | $ 44.4 B | USA |
 |
Nephros
NEPH
|
-144 M | $ 2.81 | -1.75 % | $ 29.2 M | USA |
 |
OraSure Technologies
OSUR
|
-172 M | $ 3.05 | -1.14 % | $ 224 M | USA |
 |
Repligen Corporation
RGEN
|
433 M | $ 116.46 | -0.42 % | $ 6.49 M | USA |